| 國家衛生研究院 |
2021-08-12 |
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
|
Huang, JF;Dai, CY;Huang, CF;Tsai, PC;Yeh, ML;Hsu, PY;Huang, SF;Bair, MJ;Hou, NJ;Huang, CI;Liang, PC;Lin, YH;Wang, CW;Hsieh, MY;Chen, SC;Lin, ZY;Yu, ML;Chuang, WL |
| 高雄醫學大學 |
2012 |
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
|
黃志富;余明隆;黃釧峰;卓夙航;戴嘉言;謝明彥;侯乃仁;葉明倫;謝孟軒;楊正福;林子堯;陳信誠;辛鍚章;莊萬龍 ; Huang JF;Yu ML;Huang CF;Juo SH;Dai CY;Hsieh MY;Hou NJ;Yeh ML;Hsieh MH;Yang JF;Lin ZY;Chen SC;Shin SJ;Chuang WL. |
| 高雄醫學大學 |
2011 |
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial.
|
黃志富;余明隆;黃釧峰;丘長富;戴嘉言;黃駿逸;葉明倫;楊正福;謝明彥;侯乃仁;林子堯;陳信成;王良彥;莊萬龍 ; Huang JF;Yu ML;Huang CF;Chiu CF;Dai CY;Huang CI;Yeh ML;Yang JF;Hsieh MY;Hou NJ;Lin ZY;Chen SC;Wang LY;Chuang WL. |
| 高雄醫學大學 |
2009 |
慢性C型肝炎患者接受長效型干擾素合併治療引起之中性白血球低下與細菌感染之關係
|
楊正福;謝明彥;侯乃仁;戴嘉言;黃志富;林子堯;陳信成;謝明裕;王良彥;莊萬龍;余明隆 ; Yang JF;Hsieh MY;Hou NJ;Dai CY;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chuang WL;Yu ML. |
| 高雄醫學大學 |
2009 |
Insight into Alcohol Consumption-Related Problems and Its Correlates Among Taiwanese Alcoholic Hepatogastroenterological Clinic Patients.
|
顏正芳;戴嘉言;侯乃仁;余明隆 ; Yen CF;Dai CY;Hou NJ;Hsiao RC;Yu ML |
| 高雄醫學大學 |
2009 |
胰島素阻抗可預測慢性C型肝炎病毒以長效干擾素合併ribavirin合併治療之反應
|
戴嘉言;黃志富;謝明彥;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍;余明隆 ; Dai CY;Huang JF;Hsieh MY;Hou NJ;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL;Yu ML |
| 高雄醫學大學 |
2008 |
Transforming growth factor-beta 1基因多型性與慢性C型肝炎病毒特徵之關聯
|
戴嘉言;莊萬龍;李立柏;潘文正;黃志富;謝明彥;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;余明隆 ; Dai CY;Chuang WL;Li-Po Lee;Pan WC;Huang JF;Hsieh MY;Hou NJ;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Yu ML |
| 高雄醫學大學 |
2008 |
Hepatitis C virus infection among children in aboriginal areas in Taiwan.
|
吳大中;莊萬龍;戴嘉言;黃志富;謝明彥;侯乃仁;李立柏;林子堯;楊正福;邱昭景;陳信成;謝明裕;張文宇;余明隆 ; Wu TC;Chuang WL;Dai CY;Huang JF;Hsieh MY;Hou NJ;Lee LP;Lin WY;Yang JF;Chiu CC;Chen SC;Hsieh MY;Chang WY;Yu ML |
| 高雄醫學大學 |
2008 |
Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.
|
謝明彥;戴嘉言;黃志富;李立柏;侯乃仁;莊萬龍;余明隆 ; Heish MY;Dai CY;Huang JF;Lee LP;Hou NJ;Chuang WL;Yu ML |
| 高雄醫學大學 |
2008 |
C型肝炎病毒血症與較低之血清三酸甘油脂及膽固醇值相關:一社區研究
|
戴嘉言;莊萬龍;何啟功;謝明彥;黃志富;李立柏;侯乃仁;林子堯;陳信成;謝明裕;王良彥;蔡榮發;張文宇;余明隆; Dai, CY;Chuang, WL;Ho, CK;Hsieh, MY;Huang, JF;Lee, LP;Hou, NJ;Lin, ZY;Chen, SC;Hsieh, MY;Wang, LY;Tsai, JF;Chang, WY;Yu, ML |
| 高雄醫學大學 |
2007 |
干適能治療干安能抗藥性突變株B型肝炎病毒
|
戴嘉言;莊萬龍;謝明彥;李立柏;黃志富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;蔡榮發;張文宇;余明隆 ; Dai CY;Chuang WL;Hsieh MY;Lee LP;Huang JF;Hou NJ;Lin ZY;Chen SC;Hsieh MY;Wang LY;Tsai JF;Chang WY;Yu ML |
| 高雄醫學大學 |
2007 |
在台灣慢性C型肝炎之肝臟脂肪變性及肝臟纖維化
|
謝孟軒;李立柏;謝明彥;蔡坤寶;黃志富;侯乃仁;陳信成;林子堯;謝明裕;王良彥;戴嘉言;莊萬龍;余明隆 ; Hsieh MH;Lee LP;Hsieh MY;Tsai KB;Huang JF;Hou NJ;Chen SC;Lin ZY;Hsieh MY;Wang LY;Dai CY;Chuang WL;Yu ML |
| 高雄醫學大學 |
2007 |
Links between triglyceride levels; hepatitis C virus infection and diabetes.
|
戴嘉言;黃志富;謝明彥;李立柏;侯乃仁;余明隆;莊萬龍 ; Dai CY;Huang JF;Hsieh MY;Lee LP;Hou NJ;Yu ML;Chuang WL |
| 高雄醫學大學 |
2007 |
(在台灣慢性C型肝炎之肝臟脂肪變性及肝臟纖維化)
|
謝孟軒;李立柏;謝明彥;蔡坤寶;黃志富;侯乃仁;陳信成;林子堯;謝明裕;王良彥;戴嘉言;莊萬龍;余明隆 ; Hsieh MH;Lee LP;Hsieh MY;Tsai KB;Huang JF;Hou NJ;Chen SC;Lin ZY;Hsieh MY;Wang LY;Dai CY;Chuang WL;Yu ML |
| 高雄醫學大學 |
2006 |
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
|
余明隆;戴嘉言;李立柏;謝明彥;侯乃仁;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Yu ML;Dai CY;Lee LP;Hsieh MY;Hou NJ;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL |
| 高雄醫學大學 |
2006 |
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
|
戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;黃志富;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Huang JF;Hsieh MY;Wang LY;Yu ML |
| 高雄醫學大學 |
2005 |
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.
|
戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Hsieh MY;Wang LY;Yu ML |
| 高雄醫學大學 |
2005 |
Polymorphisms in the interferon-gamma gene at position+874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin
|
戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Hsieh MY;Wang LY;Yu ML |
| 高雄醫學大學 |
2005 |
Successful treatment of fulminant Hepatitis C by therapy with Alpha Interferon and Ribavirin
|
余明隆;侯乃仁;戴嘉言;張文宇;莊萬龍 ; Yu ML;Hou NJ;Dai CY;Chang WY;Chuang WL |
| 高雄醫學大學 |
2005 |
Tumor necrosis factor alpha promoter polymorphism at position-308 predicts hepatitis C virus response to combination therapy with high dose interferon and ribavirin
|
戴嘉言;余明隆;莊萬龍;李立柏;謝明裕;侯乃仁;張文宇 ; Dai CY;Yu ML;Chuang WL;Lee LP;Hsieh MY;Hou NJ;Chang WY |
| 高雄醫學大學 |
2003 |
以新型引子評估接受高劑量干擾素治療之慢性C型肝炎病患TT病毒之臨床表徵
|
戴嘉言;余明隆;陳信成;謝明裕;李立柏;侯乃仁;謝明裕;王良彥;蔡榮發;莊萬龍;張文宇 ; Dai CY;Yu ML;Lin ZY;Chen SC;Hsieh MY;Lee LP;Hou NJ;Hsieh MY;Wang LY;Tsai JF;Chuang WL;Chang WY |
